Inhibition of energy metabolism down-regulates the Alzheimer related presenilin 2 gene

Journal of Neural Transmission

Volumn 110, Issue 9, 2003, Pages 1029-1039

  Ghidoni, R ^a   Gasparini, L ^a   Alberici, A ^a   Benussi, L ^a   Barbiero, L ^a   Mazzoli, F ^a   Nicosia, F ^a   Finazzi, D ^a   Gatta, L Benerini ^a   Albertini, A ^a   Zanetti, O ^a   Binetti, G ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Nonradioactive RPA; Oxidative stress; PS2 expression

Indexed keywords

ANTIOXIDANT; MESSENGER RNA; PRESENILIN 2; SODIUM AZIDE; TRANSCRIPTION FACTOR;

ALZHEIMER DISEASE; ARTICLE; BRAIN; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; MITOCHONDRION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION;

ALZHEIMER DISEASE; ANTIOXIDANTS; BRAIN; CELL LINE, TUMOR; DOWN-REGULATION; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PRESENILIN-2; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SODIUM AZIDE; TRANSCRIPTION FACTORS;

EID: 10744226331     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-003-0015-9     Document Type: Article

References (28)

1. Alberici A, Moratto D, Benussi L, Gasparini L, Ghidoni R, Gatta LB, Finazzi D, Frisoni GB, Trabucchi M, Growdon JH, Nitsch RM, Binetti G (1999) Presenilin 1 protein directly interacts with Bcl-2. J Biol Chem 274(43): 30764-30769
2. Alves da Costa C, Paitel E, Mattson MP, Amson R, Telerman A, Ancolio K, Checler F, Mattson MP (2002) Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons. PNAS 99(6): 4043-4048
3. Ammendola R, Mesuraca M, Russo T, Cimino F (1994) The DNA-binding efficiency of Sp1 is affected by redox changes. Eur J Biochem 225: 483-489
4. Andrews NC, Faller DV (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucl Acids Res 19: 2499
5. Benkovic SA, McGowan EM, Rothwell NJ, Hutton M, Morgan DG, Gordon MN (1997) Regional and cellular localization of presenilin-2 RNA in rat and human brain. Exp Neurol 145: 555-564
6. Chandrasekaran K, Hatanpaa K, Rapoport SI, Brady DR (1997) Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease. Brain Res Mol Brain Res 44: 99-104
7. Deng G, Pike CJ, Cotman CW (1996) Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells. FEBS Lett 397(1): 50-54
8. Finckh U, Alberici A, Antoniazzi M, Benussi L, Fedi V, Giannini C, Gal A, Nitsch RM, Binetti G (2000) Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I. Neurology 54: 2006-2008
9. Ghosh R, Mitchell DL (1999) Effect of oxidative DNA damage in promoter elements on transcription factor binding. Nucl Acids Res 27(15): 3213-3218
10. Hoyer S (2000) Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update. Exp Gerontol 35(9-10): 1363-1372
11. Janicki S, Monteiro MJ (1997) Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N141I). J Cell Biol 139(2): 485-495
12. Kovacs DM, Fausett HJ, Page KJ, Kim TW, Moir RD, Merriam DE, Hollister RD, Hallmark OG, Mancini R, Felsenstein KM, Hyman BT, Tanzi RE, Wasco W (1996) Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat Med 2(2): 224-229
13. Lee M, Slunt H, Martin L, Thinkaran G, Kim G, Gandy S, Seeger M, Koo E, Price D, Sisodia S (1996) Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J Neurosci 16(23): 7513-7525
14. Markesbery WR, Carney JM (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol 9(1): 133-146
15. McMillan PJ, Leverenz JB, Poorkaj P, Schellenberg GD, Dorsa DM (1996) Neuronal expression of STM2 mRNA in human brain is reduced in Alzheimer's disease. J Histochem Cytochem 44(11): 1215-1222
16. McMillan PJ, Leverenz JB, Dorsa DM (2000) Specific downregulation of presenilin 2 gene expression is prominent during early stages of sporadic late-onset Alzheimer's disease. Brain Res Mol Brain Res 78(1-2): 138-145
17. Morel Y, Barouki R (1999) Repression of gene expression by oxidative stress. Biochem J 342: 481-496
18. Mutisya EM, Bowling AC, Beal MF (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem 63(6): 2179-2184
19. Parker WD Jr, Filley CM, Parks JK (1990) Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40(8): 1302-1303
20. Partridge RS, Monroe SM, Parks JK, Johnson K, Parker WD Jr, Eaton GR, Eaton SS (1994) Spin trapping of azidyl and hydroxyl radicals in azide-inhibited rat brain submitochondrial particles. Arch Biochem Biophys 310(1): 210-217
21. Pennypacker KR, Fuldner R, Xu R, Hernandez H, Dawbarn D, Mehta N, Perez-Tur J, Bake M, Hutton M (1998) Cloning and characterization of the presenilin-2 gene promoter. Brain Res Mol Brain Res 56(1-2): 57-65
22. Refolo LM, Eckman C, Prada CM, Yager D, Sambamurti K, Mehta N, Hardy J, Younkin SG (1999) Antisense-induced reduction of presenilin 1 expression selectively increases the production of amyloid beta42 in transfected cells. J Neurochem 73(6): 2383-2388
23. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Piacentini S, Amaducci L, Chumakov I, Cohen D, Lannfelt L, Fraser PE, Rommens JM, George-Hyslop PH (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376: 775-778
24. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346(7): 476-483
25. Smith TS, Bennett JP Jr (1997) Mitochondrial toxins in models of neurodegenerative diseases. I. In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions. Brain Res 765(2): 183-188
26. Takami K, Terai K, Matsuo A, Walker DG, McGeer PL (1997) Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer's disease brains. Brain Res 748: 122-130
27. Theuns J, Van Broeckhoven C (2000) Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility. Hum Mol Genet 9(16): 2383-2394
28. Wolozin B, Iwasaki K, Vito P, Ganjei JK, Lacanà E, Sunderland T, Zhao B, Kusiak JW, Wasco W, D'Adamio L (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274(5293): 1710-1713